Peter Heeringa

14.6k total citations · 2 hit papers
226 papers, 10.7k citations indexed

About

Peter Heeringa is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Immunology and Allergy. According to data from OpenAlex, Peter Heeringa has authored 226 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Pulmonary and Respiratory Medicine, 127 papers in Immunology and 49 papers in Immunology and Allergy. Recurrent topics in Peter Heeringa's work include Vasculitis and related conditions (124 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (63 papers) and Cell Adhesion Molecules Research (49 papers). Peter Heeringa is often cited by papers focused on Vasculitis and related conditions (124 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (63 papers) and Cell Adhesion Molecules Research (49 papers). Peter Heeringa collaborates with scholars based in Netherlands, United States and Pakistan. Peter Heeringa's co-authors include J. Charles Jennette, Ronald J. Falk, Hong Xiao, Cees G. M. Kallenberg, Coen A. Stegeman, Nobuyo Maeda, Peiqi Hu, Yasuaki Aratani, Menno P.J. de Winther and Ming‐Lang Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peter Heeringa

219 papers receiving 10.5k citations

Hit Papers

Antineutrophil cytoplasmic autoantibodies specific for my... 2002 2026 2010 2018 2002 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
    2002 791 citations Hong Xiao, Peter Heeringa et al. profile →
  2. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
    2002 689 citations Hong Xiao, Peter Heeringa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Heeringa Netherlands 52 5.3k 4.6k 2.3k 1.9k 1.8k 226 10.7k
Rolf A.K. Stahl Germany 59 1.9k 0.4× 3.4k 0.7× 2.9k 1.3× 1.1k 0.6× 4.8k 2.7× 257 12.2k
Curtis B. Wilson United States 52 1.9k 0.3× 3.5k 0.8× 2.2k 0.9× 1.5k 0.8× 2.9k 1.6× 154 10.2k
David J. Nikolic‐Paterson Australia 70 2.2k 0.4× 4.7k 1.0× 5.9k 2.6× 1.1k 0.6× 6.0k 3.4× 244 17.6k
Takao Koike Japan 56 787 0.1× 2.9k 0.6× 1.8k 0.8× 6.4k 3.4× 981 0.6× 332 12.4k
Carla Zoja Italy 69 1.2k 0.2× 2.4k 0.5× 3.4k 1.5× 558 0.3× 4.8k 2.7× 192 13.3k
Jeremy Hughes United Kingdom 45 1.3k 0.2× 2.3k 0.5× 2.8k 1.2× 828 0.4× 3.0k 1.7× 112 8.8k
Stuart J. Shankland United States 70 1.5k 0.3× 1.8k 0.4× 6.8k 3.0× 816 0.4× 8.4k 4.8× 229 15.2k
Clemens D. Cohen Germany 57 1.0k 0.2× 2.1k 0.4× 3.7k 1.6× 840 0.4× 3.7k 2.1× 146 9.8k
Johan van der Vlag Netherlands 62 681 0.1× 3.1k 0.7× 4.9k 2.1× 1.3k 0.7× 2.3k 1.3× 205 10.7k
Peter W. Mathieson United Kingdom 53 1.1k 0.2× 1.9k 0.4× 3.1k 1.4× 534 0.3× 5.1k 2.9× 178 9.4k

Countries citing papers authored by Peter Heeringa

Since Specialization
Citations

This map shows the geographic impact of Peter Heeringa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Heeringa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Heeringa more than expected).

Fields of papers citing papers by Peter Heeringa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Heeringa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Heeringa. The network helps show where Peter Heeringa may publish in the future.

Co-authorship network of co-authors of Peter Heeringa

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Heeringa. A scholar is included among the top collaborators of Peter Heeringa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Heeringa. Peter Heeringa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kissel, Theresa, Diane van der Woude, Karin A. van Schie, et al.. (2025). Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nature Communications. 16(1). 1582–1582. 2 indexed citations
2.
Ricaño-Ponce, Isis, Anneke C. Muller Kobold, Simone van der Sar–van der Brugge, et al.. (2024). Delineating sex-specific circulating host response signatures associated with COVID-19 severity and mortality. iScience. 27(11). 111150–111150. 1 indexed citations
3.
Xu, Shuang, William F. Jiemy, Annemieke M. H. Boots, et al.. (2024). Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis. Arthritis Care & Research. 76(9). 1322–1332. 6 indexed citations
4.
Mescia, Federica, Shaghayegh Bayati, Peter Heeringa, et al.. (2023). Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis. International Journal of Molecular Sciences. 24(20). 15341–15341. 3 indexed citations
5.
Arends, Suzanne, Berit Dalsgaard Nielsen, Philip Therkildsen, et al.. (2023). Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort. RMD Open. 9(1). e002640–e002640. 9 indexed citations
6.
Stegeman, Coen A., Ernesto J. Muñoz‐Elías, Eric J. Tarcha, et al.. (2023). Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis. Lara D. Veeken. 63(1). 198–208. 5 indexed citations
7.
Kobold, Anneke C. Muller, Simone van der Sar–van der Brugge, Peter Heeringa, et al.. (2022). Circulating adipokine levels and COVID-19 severity in hospitalized patients. International Journal of Obesity. 47(2). 126–137. 26 indexed citations
8.
Geest, Kornelis S. M. van der, Maria Sandovici, William F. Jiemy, et al.. (2022). Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8+ T cells in giant cell arteritis. Lara D. Veeken. 62(1). 417–427. 13 indexed citations
9.
Rutgers, Abraham, et al.. (2021). The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis. Current Rheumatology Reports. 23(7). 54–54. 8 indexed citations
10.
Abdulahad, Wayel H., et al.. (2021). B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells. Cells. 10(5). 1190–1190. 36 indexed citations
11.
Meurs, Matijs van, et al.. (2020). Effects of propofol and dexmedetomidine with and without remifentanil on serum cytokine concentrations in healthy volunteers: a post hoc analysis. British Journal of Anaesthesia. 125(3). 267–274. 4 indexed citations
12.
Reijnders, Tom D. Y., Coen A. Stegeman, Minke G. Huitema, et al.. (2019). Unraveling the identity of FoxP3+ regulatory T cells in Granulomatosis with Polyangiitis patients. Scientific Reports. 9(1). 8273–8273. 9 indexed citations
13.
Sleen, Yannick van, Qi Wang, Kornelis S. M. van der Geest, et al.. (2017). Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis. Scientific Reports. 7(1). 6553–6553. 47 indexed citations
14.
Land, J. A., Wayel H. Abdulahad, Suzanne Arends, et al.. (2017). Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis. PLoS ONE. 12(8). e0182549–e0182549. 11 indexed citations
15.
Veen, Betty S. van der, Menno P.J. de Winther, & Peter Heeringa. (2009). Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease. Antioxidants and Redox Signaling. 11(11). 2899–2937. 444 indexed citations
16.
Ásgeirsdóttir, Sigrídur A., Peter J. Zwiers, Henriëtte W. M. Morselt, et al.. (2007). Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. American Journal of Physiology-Renal Physiology. 294(3). F554–F561. 84 indexed citations
17.
Veen, Betty S. van der, et al.. (2007). Induction of CXCR2 expression and its ligands in experimental anti-MPO IgG induced glomerulonephritis. Data Archiving and Networked Services (DANS). 1 indexed citations
18.
Xiao, Hong, Peter Heeringa, Peiqi Hu, et al.. (2002). Induction of Necrotizing and Crescentic Glomeru-Lonephritis (NCGN) and Small-Vessel Vasculitis (SVV) by Adoptive Transfer of Anti-Myeloperoxidase (Anti-MPO) Lymphocytes into Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice. Cleveland Clinic Journal of Medicine. 69. 1 indexed citations
19.
Foucher, Pascal, Peter Heeringa, Arjen H. Petersen, et al.. (1999). Antimyeloperoxidase-associated Lung Disease: An Experimental Model. American Journal of Respiratory and Critical Care Medicine. 160(3). 987–994. 44 indexed citations
20.
Weening, Jan J., Peter Heeringa, Liesbeth Brouwer, Jan Willem Cohen Tervaert, & Cornelis Kallenberg. (1998). Models of antineutrophil cytoplasmic antigen-associated systemic vasculitis and their clinical relevance.. University of Groningen research database (University of Groningen / Centre for Information Technology). 28. 63–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rolf A.K. Stahl Breakdown of academic impact, for papers by Curtis B. Wilson Breakdown of academic impact, for papers by David J. Nikolic‐Paterson Breakdown of academic impact, for papers by Takao Koike Breakdown of academic impact, for papers by Carla Zoja Breakdown of academic impact, for papers by Jeremy Hughes Breakdown of academic impact, for papers by Stuart J. Shankland Breakdown of academic impact, for papers by Clemens D. Cohen Breakdown of academic impact, for papers by Johan van der Vlag Breakdown of academic impact, for papers by Peter W. Mathieson
Rankless by CCL
2026